iCAD Inc is a United Statesâ€‘based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AIâ€‘driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

25-07-20	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI

Market Cap	106M 91.5M 86.35M 78.33M 147M 10.12B 148M 1.03B 397M 5.13B 397M 388M 16.32B	P/E 2023	-9.35x	P/E 2024	-8.59x
Enterprise Value	88.75M 76.9M 72.57M 65.84M 124M 8.51B 124M 867M 334M 4.32B 333M 326M 13.72B	EV / Sales 2023	1.47x	EV / Sales 2024	1.6x
Free-Float	99.32%	Yield 2023 *	-	Yield 2024	-

25-07-20	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Growth Benchmark Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Value Benchmark	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Growth Benchmark	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Growth Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell 3000E Value Index	CI
25-07-17	RadNet, Inc. completed the acquistion of iCAD, Inc..	CI
25-07-17	RadNet's DeepHealth Unit Closes iCAD Acquisition	MT
25-07-16	ICAD, Inc.(NasdaqCM:ICAD) dropped from NASDAQ Composite Index	CI
25-05-13	ICAD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI

25-04-17	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
25-04-17	BTIG Research Downgrades iCAD to Neutral From Buy	MT
23-07-19	Lake Street Adjusts Price Target on icad to $5 From $2.50, Maintains Buy Rating	MT
23-04-13	JMP Securities Adjusts iCAD's Price Target to $4 From $7, Keeps Outperform Rating	MT
23-04-04	Oppenheimer Adjusts iCAD Price Target to $4 From $5, Maintains Outperform Rating	MT

25-07-08	ICAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.	AQ
25-06-03	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU
25-05-13	ICAD Reports Financial Results for First Quarter Ended March 31, 2025	AQ
25-04-29	ICAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)	AQ
25-04-17	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU

iCAD Inc Stock Nasdaq

Stocks

US44934S1078

Advanced Medical Equipment & Technology

Valuation: iCAD Inc

Latest news: iCAD Inc

Analysts' recommendations: iCAD Inc

Press Releases: iCAD Inc

News in other languages: iCAD Inc

Managers and Directors: iCAD Inc

Other Advanced Medical Equipment & Technology

Financials

Company Profile

23-03-13	LA PREMIÈRE ÉTAPE DE L’OPÉRATION CONSISTE EN LA CESSION PAR ICAD…
21-04-26	CAC 40 : Les valeurs à suivre à Paris et en Europe
21-04-26	Les valeurs à suivre à Paris et en Europe (actualisé)
19-10-18	ICAD : annonce l’installation de la solution ProFound AI™ 2D pour la mammographie et pour la tomosynthèse (DBT) 3D au Centre d’Imagerie Paris Nord Sarcelles
19-01-25	Dow Jones Industrial Average : Wall Street attendue en hausse malgré Intel et les doutes sur la croissance

Manager	Title	Age	Since
Dana Brown CEO	Chief Executive Officer	61	2023-03-09
Mark Stolper DFI	Director of Finance/CFO	54	2025-07-16
Dave Katz SEC	Corporate Secretary	-	2025-07-16

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	+0.62%	-0.03%	+27.98%	+19.00%	227B
DANAHER CORPORATION	+1.55%	-2.12%	+6.95%	-19.82%	143B
INTUITIVE SURGICAL, INC.	+2.38%	+3.07%	-15.95%	+24.43%	134B
BOSTON SCIENTIFIC CORPORATION	+4.82%	-5.75%	-56.14%	-14.87%	65.29B
SIEMENS HEALTHINEERS AG	-0.54%	-0.79%	-19.08%	-16.13%	50.09B
EDWARDS LIFESCIENCES CORPORATION	+1.36%	-4.87%	+10.25%	+15.54%	49.29B
AGILENT TECHNOLOGIES, INC.	-0.09%	-2.69%	+19.12%	+27.79%	41.39B
WATERS CORPORATION	+0.41%	+0.15%	+38.80%	+50.73%	40.28B
RESMED, INC.	+2.16%	-2.35%	-17.45%	+51.04%	31.9B
Average	+1.41%	-1.73%	-0.61%	+15.30%	86.84B
Weighted average by Cap.	+1.43%	-0.91%	+3.70%	+10.94%

	2023	2024
Net sales	17.32M 15.01M 14.16M 12.85M 24.1M 1.66B 24.27M 169M 65.17M 842M 65.04M 63.61M 2.68B	19.61M 16.99M 16.03M 14.55M 27.29M 1.88B 27.48M 191M 73.79M 953M 73.65M 72.02M 3.03B
Net income	-4.85M -4.2M -3.96M -3.6M -6.75M -465M -6.79M -47.34M -18.24M -236M -18.2M -17.8M -749M	-5.62M -4.87M -4.59M -4.17M -7.82M -538M -7.87M -54.85M -21.13M -273M -21.09M -20.63M -868M
Net Debt	-21.21M -18.38M -17.34M -15.73M -29.51M -2.03B -29.73M -207M -79.81M -1.03B -79.66M -77.9M -3.28B	-16.84M -14.6M -13.77M -12.5M -23.44M -1.61B -23.61M -164M -63.39M -819M -63.26M -61.87M -2.6B

End-of-day quote Nasdaq
- ^USD	-